Ontology highlight
ABSTRACT: Importance
Immune checkpoint inhibitors (ICIs) are now a mainstay of cancer treatment. Although rare, fulminant and fatal toxic effects may complicate these otherwise transformative therapies; characterizing these events requires integration of global data.Objective
To determine the spectrum, timing, and clinical features of fatal ICI-associated toxic effects.Design, setting, and participants
We retrospectively queried a World Health Organization (WHO) pharmacovigilance database (Vigilyze) comprising more than 16 000 000 adverse drug reactions, and records from 7 academic centers. We performed a meta-analysis of published trials of anti-programmed death-1/ligand-1 (PD-1/PD-L1) and anti-cytotoxic T lymphocyte antigen-4 (CTLA-4) to evaluate their incidence using data
SUBMITTER: Wang DY
PROVIDER: S-EPMC6440712 | biostudies-literature | 2018 Dec
REPOSITORIES: biostudies-literature